These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 25451017

  • 1. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A, Ayoobzadehshirazi A.
    Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
    [Abstract] [Full Text] [Related]

  • 2. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2015 Jan; 38(1):11-7. PubMed ID: 25580916
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
    Mohammadi MR, Yadegari N, Hassanzadeh E, Farokhnia M, Yekehtaz H, Mirshafiee O, Akhondzadeh S.
    Clin Neuropharmacol; 2013 Jan; 36(6):179-84. PubMed ID: 24201232
    [Abstract] [Full Text] [Related]

  • 4. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S.
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezazadeh SA, Akhondzadeh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1269-72. PubMed ID: 20637249
    [Abstract] [Full Text] [Related]

  • 6. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R, Ghajar A, Mesgarpour B, Afarideh M, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb 01; 28(1):74-81. PubMed ID: 29027815
    [Abstract] [Full Text] [Related]

  • 7. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Moazen-Zadeh E, Shirzad F, Karkhaneh-Yousefi MA, Khezri R, Mohammadi MR, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2018 Feb 01; 28(1):82-89. PubMed ID: 28719227
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
    Ghanizadeh A, Moghimi-Sarani E.
    BMC Psychiatry; 2013 Jul 25; 13():196. PubMed ID: 23886027
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
    Ghaleiha A, Rasa SM, Nikoo M, Farokhnia M, Mohammadi MR, Akhondzadeh S.
    Psychiatry Res; 2015 Sep 30; 229(1-2):181-7. PubMed ID: 26208985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR, Hafezi P, Galeiha A, Hajiaghaee R, Akhondzadeh S.
    Acta Med Iran; 2012 Sep 30; 50(11):723-8. PubMed ID: 23292622
    [Abstract] [Full Text] [Related]

  • 14. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H, Moghaddam HS, Mohammadi MR, Akhondzadeh S.
    Clin Neuropharmacol; 2019 Sep 30; 42(6):189-196. PubMed ID: 31725473
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S.
    Psychopharmacology (Berl); 2013 Jan 30; 225(1):51-9. PubMed ID: 22782459
    [Abstract] [Full Text] [Related]

  • 16. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
    Ghaleiha A, Alikhani R, Kazemi MR, Mohammadi MR, Mohammadinejad P, Zeinoddini A, Hamedi M, Shahriari M, Keshavarzi Z, Akhondzadeh S.
    J Child Adolesc Psychopharmacol; 2016 Nov 30; 26(9):784-791. PubMed ID: 27128958
    [Abstract] [Full Text] [Related]

  • 17. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Ghaleiha A, Asadabadi M, Mohammadi MR, Shahei M, Tabrizi M, Hajiaghaee R, Hassanzadeh E, Akhondzadeh S.
    Int J Neuropsychopharmacol; 2013 May 30; 16(4):783-9. PubMed ID: 22999292
    [Abstract] [Full Text] [Related]

  • 18. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ, Kodesh A, Goldberg Y, Reichenberg A, Furukawa TA, Kolevzon A, Leucht S.
    Eur Psychiatry; 2016 Feb 30; 32():16-20. PubMed ID: 26802979
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):32-6. PubMed ID: 19772883
    [Abstract] [Full Text] [Related]

  • 20. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.
    J Child Adolesc Psychopharmacol; 2015 Aug 01; 25(6):482-93. PubMed ID: 26262903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.